Clinical Trials Sponsored by Jiangsu vcare pharmaceutical technology co., LTD

Total 580 results

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

An Add-on Study to Evaluate the Efficacy and Safety of Xiyanping Injection in Pediatric Bronchitis Patients.

Bronchitis

China
Wuhan Union Hospital, China
Jiangsu HengRui Medicine Co., Ltd.; CSPC ZhongQi Pharmaceutical Technology...

Not yet recruiting

Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy

Breast Cancer

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Not yet recruiting

A Phase I Study of BR790 in Subjects With Advanced Solid Tumors

Advanced Solid Tumor
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Recruiting

Study of SC10914 in Patients With gBRCA1/2 Mutation Advanced Ovarian Cancer

Advanced Ovarian Cancer

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Completed

A Clinical Study on the Safety and Efficacy of GP681 Tablets in the Treatment of Uncomplicated Acute Influenza

Influenza

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia

2019 Novel Coronavirus Pneumonia
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

Evaluation the Clinical Value of Xiyanping Injection in the Treatment of Community-acquired Pneumonia in Children

Community Acquired Pneumonia
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

Phase Ⅱc Sutdy of Aolanti Weikang Tablets in FD PDS Patients

Functional Dyspepsia

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Tonsillitis

Acute Tonsillitis

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Bronchitis

Acute Bronchitis

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Unknown

A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic Bronchitis

Acute Exacerbation of Chronic Bronchitis

China
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
PPD Development, L.P.

Recruiting

DZD9008 PK Study in Hepatic Impairment Subjects

Hepatic Impairment

United States
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.
Tigermed Consulting Co., Ltd

Completed

Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

China
Beijing Tiantan Hospital
Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd; The Place Pharmaceutical(Jiangsu)...

Recruiting

Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）

Acute Ischemic Stroke

China
Beijing Tiantan Hospital
Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd; The Place Pharmaceutical(Jiangsu)...

Active, not recruiting

Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-II）

Acute Ischemic Stroke

China
Jiangsu Healthy Life Innovation Medical Technology...

Not yet recruiting

TTField in Combination With TMZ and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.

Glioblastoma Multiforme
Jiangsu Famous Medical Technology Co., Ltd.
Ruijin Hospital

Completed

Clinical Trial Scheme of Tanreqing Capsules in the Treatment of COVID-19

Novel Coronavirus Pneumonia

China
Overseas Pharmaceuticals, Ltd.
Guangzhou Health Start Pharmaceutical Techology Co.,Ltd

Not yet recruiting

An Comparative Pharmacokinetic Study of Amlodipine Besylate Controlled-release Tablets,China in Normal, Healthy, Adult, Human Subjects Under Fasting Conditions

Hypertension

China
Peking University
Jiangsu Nhwa Pharmaceutical Co., Ltd.

Recruiting

Effects of Lithium on Suicide Prevention in Adolescents and Young Adults With Bipolar Disorder in China

Bipolar Disorder | Suicidal Ideation | Suicide, Attempted | Nonsuicidal Self Injury

China
Jiangsu Atom Bioscience and Pharmaceutical Co.,...

Recruiting

Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout

Gout

United States, Georgia, Australia, Guatemala, Taiwan
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd

Completed

Study on the Safety and Efficacy of Meplazumab for Injection in Severe Patients With COVID-19

COVID-19

China
Jiangsu Atom Bioscience and Pharmaceutical Co.,...

Enrolling by invitation

Extension Study of ABP-671 in Participants With Gout

Gout

United States, Georgia, Australia, Guatemala, Taiwan
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd

Withdrawn

Clinical Study of Meplazumab to Treat With Malaria

Malaria (Plasmodium Falciparum)
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd

Completed

Study to Assess the Effect of Meplazumab on COVID-19

COVID-19

Brazil
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd

Completed

To Evaluate the Safety and Efficacy of Meplazumab in Treatment of Post-COVID-19

Post-COVID-19

China
Ruijin Hospital
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Active, not recruiting

The Effectiveness and Safety of TMF in the Treatment of Chronic Hepatitis B Patients With Normal ALT. (Promote)

Chronic Hepatitis b | HBV Infection

China
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd

Withdrawn

Study on the Safety and Efficacy of Meplazumab for Injection Patients COVID-19

COVID-19

China
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd

Completed

the Safety and Efficacy of Meplazumab in Patients With COVID-19

Covid19

China
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.

Enrolling by invitation

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Evidence of Antitumor Activity of FHND5071 as a Single Agent in Adult Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Jiangsu Atom Bioscience and Pharmaceutical Co.,...

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671 in Healthy Subjects

Hyperuricemia | Gout

United States
Jiangsu Atom Bioscience and Pharmaceutical Co.,...

Completed

Study to Investigate the Effects of Food on Relative Bioavailability of ABP-671 Tablets in Healthy Subjects

Gout | Food-drug Interaction

United States
RenJi Hospital
Jiangsu Kanion Pharmaceutical Co., Ltd

Unknown

Ginkgo Diterpene Lactone Meglumine Injection on Platelet Reactivity in Acute Ischemic Stroke (GDPRS)

Ischemic Stroke
Jiangsu Atom Bioscience and Pharmaceutical Co.,...

Recruiting

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral ABP-745 Administration in Healthy Volunteers (ABP-745)

Gout

United States
Jiangsu ProteLight Pharmaceutical & Biotechnology...
Parexel

Not yet recruiting

Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers (PL-5)

Diabetic Foot Ulcers

United States
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd

Recruiting

Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed With Plasmodium Falciparum

Malaria

Kenya
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.

Recruiting

A Study Evaluating Safety, Tolerability and Clinical Activity of FHND6091 in Patients With Multiple Myeloma

Multiple Myeloma

China
Jiangsu Atom Bioscience and Pharmaceutical Co.,...

Completed

A Study to Assess the Efficacy, Safety, and Pharmacokinetics of ABP-671 in Patients With Gout or Hyperuricemia

Hyperuricemia | Gout

Australia
Qianfoshan Hospital
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Unknown

Camrelizumab Combined With Apatinib in the Treatment of Epithelial Ovarian Cancer

Immune Checkpoint Inhibition

China
Jiangsu Atom Bioscience and Pharmaceutical Co.,...

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671

Hyperuricemia | Gout

United States
Jiangsu Healthy Life Innovation Medical Technology...

Not yet recruiting

Phase Ⅱ/Ⅲ Clinical Study of Tumor Treating Fields （EFE-P100）Combined With Docetaxel in the Treatment of Stage IV Non-small Cell Lung Cancer Patients With Disease Progression After Platinum-based Chemotherapy and Anti-programmed Death 1（PD-1)/Programmed Cell Death-Ligand 1(PD-L1) Antibody Treatment

Non-small Cell Lung Cancer (NSCLC)

China
Jiangsu Healthy Life Innovation Medical Technology...

Not yet recruiting

Clinical Study of Tumor Treating Fields Combined With Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer

Locally Advanced Pancreatic Cancer

China
Shanghai Runshi Pharmaceutical Technology Co., Ltd

Not yet recruiting

Relative Bioavailability and Food Effect of SYHA1813 Oral Solution in Healthy Participants

Healthy Participants
Shanghai Medinno Pharmaceutical Technology Co.,...

Recruiting

A Study of MDI-1228_mesylate Ophthalmic Solution in Healthy Adults

Allergic Conjunctivitis

Australia
Shenzhen Yangli Pharmaceutical Technology Co., Ltd

Recruiting

Study of TFX06 in Women With Advanced Breast Cancer.

Metastatic Breast Cancer | ER+, HER2- Advanced Breast Cancer

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Recruiting

A Study to Compare the Efficacy and Safety of HB1801 to Taxotere in Advanced Non-Small Cell Lung Cancer (NSCLC)

Locally Advanced or Metastatic Non-Small Cell Lung Cancer

China
Suzhou Puhe Pharmaceutical Technology Co., LTD

Recruiting

Assessing an Oral EGFR Inhibitor,YK-209A in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR

Treatment Side Effects | Treatment

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Not yet recruiting

A Study of Duvelisib Combined With SG001 Injection in Patient With Advanced Solid Tumors

Advanced Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Not yet recruiting

A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid Tumors

Malignant Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Not yet recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of Cisplatin Micelle Injection (HA132) in Patients With Advanced Malignant Solid Tumors

Advanced Malignant Solid Tumors

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Recruiting

A Study to Explore the Efficacy of Alprostadil Liposomes Injection in the Prevention of CI-AKI

Contrast-induced Acute Kidney Injury

China

Clinical Trials Sponsored by Jiangsu vcare pharmaceutical technology co., LTD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations